Market Research Report: iRhythm Technologies, Inc.

Company Overview

Name and Mission of the Company

• Name: iRhythm Technologies, Inc.

• Mission: To boldly innovate to create trusted solutions that detect, predict, and prevent disease.

Founding Details

• Founded by: No information is available

• Founded in: No information is available

Key People in the Company

• Chairman and CEO: Quentin Blackford

• EVP and Chief Risk Officer: Sumi Shrishrimal

• Chief Legal Officer: Patrick Murphy

• Medical Directors:

• Jay Alexander, MD, FACC, FASNC

• Hardwin Mead, MD

• Michael J. Mirro, MD, FACC, FACP

• Mehdi Razavi, MD

Headquarters

• Headquarters: 699 8th Street, Suite 600, San Francisco, CA 94103

• Other Locations:

• Deerfield, Illinois

• Houston, Texas

• Cypress, California

• Bagshot, Surrey, UK

• Mandaluyong City, Philippines

Number of Employees

• Number of Employees: No information is available

Revenue of the Company

• Revenue: No information is available

Company Specialization

• Known For: Digital healthcare solutions focusing on cardiac arrhythmia diagnostics and management.

Products

Product Offerings

Zio Service

• Description: A comprehensive ambulatory cardiac monitoring solution including single-use Zio monitors designed with patient comfort and accuracy in mind.

• Key Features:

• High Clinical Accuracy: Provides superior diagnosis accuracy.

• Patient Experience Focused: Designed for comfort and minimal disruption.

• Cost-Efficiency: Helps in lowering healthcare costs.

Zio ECG Monitors

• Zio Monitor:

• Description: Next-generation monitor designed for patient comfort with a breathable, waterproof design.

• Key Features: Lightweight, continuous ECG recording, 99% patient compliance.

• Zio XT:

• Description: Long-term continuous monitoring with comprehensive reporting capabilities.

• Key Features: Continuous recording, non-disruptive to patients' daily activities, up to 14-day wear.

• Zio AT:

• Description: Mobile Cardiac Telemetry (MCT) offering proactive, real-time monitoring and reporting.

• Key Features: Continuous recording, wear-time transmission reports, high diagnostic yield.

Recent Developments

Recent Developments in the Company

• FDA Clearance for ZEUS System: iRhythm received FDA clearance for its ZEUS System that integrates clinical services for enhanced patient monitoring.

New Products

• New Zio Monitor: Introduction of the next-generation Zio monitor with enhanced patient-centric design features.

New Features

• AI and Telehealth Integration: Emphasis on incorporating AI and telehealth functionalities within the Zio service to ease clinical workflows and patient management.

New Partnerships

• Clinical Resource Center Launch: iRhythm launched a clinical resource center to support clinicians better, enhancing its service delivery platform.

Research and Recognitions

• Health Economic Value Reports: New studies confirmed the health economic advantages of Zio by iRhythm.

• Industry Recognition: Listed among the Medtech Big 100 and San Francisco Business Times Middle Market 75 Companies.

Conclusion

This report summarizes the capabilities and strategic developments of iRhythm Technologies, Inc., highlighting its pioneering role in cardiac health diagnostics through its innovative Zio service and monitoring solutions. Note: Some specific financial and foundational details are not available.